The novel genes most frequently affected by GVs were CFTR in 5/206 (2.4%) families followed by PHYH and TRMT5 in 4/206 (1.9%) families each of the glioma cohort (Fig. 2a, Supplementary Table 3 online resource). This evidence concerns the gene TRMT5 and central nervous system cancer.